Related Experiment Video
Updated: Aug 24, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Abstract:
Deciding when to start anti-HIV therapy and what treatments to start with can leave many people feeling overwhelmed with choices. The discussion following, however, will demonstrate that the choices may be fewer and simpler than they appear at first. Charting your course of therapy options up front, outlining what therapies you will start with when you're ready and what you will switch to if that option doesn't work out, is the hallmark of long-term planning. You can then proceed to the next combination with confidence rather than being overwhelmed by the fact that your first choice didn't work out as you had expected.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

